The three top HTG-associated Reactome pathways identified here are enriched in metabolic syndrome and non-alcoholic fatty liver disease (NAFLD) in humans [38], and PAI-1 is a biomarker for metabolic syndrome [39]. This evidence concerns the gene SERPINE1 and metabolic dysfunction-associated steatotic liver disease.